Physician profile
Jitesh Vachhani
NPI 1205815487
$2,494.56
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $285 · 2021: $1,014 · 2022: $307 · 2023: $372 · 2024: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $920.58 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $422.61 | 2019-2020 | |
| Glaxosmithkline, LLC. | $249.96 | 2023 | Arexvy |
| Lilly USA, LLC | $246.82 | 2022-2023 | Jardiance |
| Novo Nordisk INC | $192.05 | 2021-2022 | |
| Insulet Corporation | $127.41 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2024 | Jynarque |
| Boston Scientific Corporation | $108.10 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $65.90 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $36.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jitesh Vachhani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.